Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis

Background: Diabetic ulcer (DU) are severe complications of diabetes, characterized by persistent inflammation, oxidative stress, and impaired mitochondrial function. Verapamil, a calcium channel blocker, has shown potential in reducing oxidative stress and improving mitochondrial dysfunction, but i...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Chen, Hang Li, Yuliang Sun, Yuhua Li, Parisa Anvari, Ghazal Shokraneh, Menglin Cong, AmirMahdi Saeidi, Hecheng Ma, Tian Li, Gang Wang, Junhao Lin, Zhijian Wei
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Materials & Design
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127525006720
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850164421112889344
author Bin Chen
Hang Li
Yuliang Sun
Yuhua Li
Parisa Anvari
Ghazal Shokraneh
Menglin Cong
AmirMahdi Saeidi
Hecheng Ma
Tian Li
Gang Wang
Junhao Lin
Zhijian Wei
author_facet Bin Chen
Hang Li
Yuliang Sun
Yuhua Li
Parisa Anvari
Ghazal Shokraneh
Menglin Cong
AmirMahdi Saeidi
Hecheng Ma
Tian Li
Gang Wang
Junhao Lin
Zhijian Wei
author_sort Bin Chen
collection DOAJ
description Background: Diabetic ulcer (DU) are severe complications of diabetes, characterized by persistent inflammation, oxidative stress, and impaired mitochondrial function. Verapamil, a calcium channel blocker, has shown potential in reducing oxidative stress and improving mitochondrial dysfunction, but its application in DU treatment remains unexplored. Methods: A dual-network QSAZ@VPH hydrogel was developed for local delivery and controlled release of verapamil. In vitro experiments evaluated its protective effects on HUVECs exposed to H2O2-induced mitochondrial dysfunction, including inflammatory marker expression, apoptosis inhibition, and angiogenesis promotion. In vivo studies used db/db mice and DU model rats to assess wound healing, granulation tissue formation, and neovascularization. Results: In vitro, QSAZ@VPH reduced mitochondrial dysfunction, lowered inflammatory markers, inhibited apoptosis, and promoted angiogenesis. In vivo, the hydrogel significantly improved wound healing in both models, reversing impaired healing and promoting granulation tissue formation and enhanced neovascularization. Conclusions: The QSAZ@VPH hydrogel presents a promising strategy for diabetic ulcer therapy by targeting mitochondrial dysfunction and promoting tissue regeneration.
format Article
id doaj-art-2e98e53970f945d5b210a3ed5a9e6887
institution OA Journals
issn 0264-1275
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Materials & Design
spelling doaj-art-2e98e53970f945d5b210a3ed5a9e68872025-08-20T02:21:59ZengElsevierMaterials & Design0264-12752025-08-0125611425210.1016/j.matdes.2025.114252Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesisBin Chen0Hang Li1Yuliang Sun2Yuhua Li3Parisa Anvari4Ghazal Shokraneh5Menglin Cong6AmirMahdi Saeidi7Hecheng Ma8Tian Li9Gang Wang10Junhao Lin11Zhijian Wei12Department of orthopedic, Department of hand and foot surgery, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of orthopedic, Department of spinal surgery, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of orthopedic, Department of hand and foot surgery, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of orthopedic, Department of spinal surgery, Qilu Hospital of Shandong University, Jinan, ChinaCheeloo College of Medicine, Shandong University, Jinan, ChinaCheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of orthopedic, Department of spinal surgery, Qilu Hospital of Shandong University, Jinan, ChinaCheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of orthopedic, Department of spinal surgery, Qilu Hospital of Shandong University, Jinan, ChinaTianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, 8, Changjiang Avenue, Tianjin 300100, China; Corresponding authors.Department of orthopedic, Department of hand and foot surgery, Qilu Hospital of Shandong University, Jinan, China; Corresponding authors.Department of orthopedic, Department of hand and foot surgery, Qilu Hospital of Shandong University, Jinan, China; Corresponding authors.Department of orthopedic, Department of spinal surgery, Qilu Hospital of Shandong University, Jinan, China; Corresponding authors.Background: Diabetic ulcer (DU) are severe complications of diabetes, characterized by persistent inflammation, oxidative stress, and impaired mitochondrial function. Verapamil, a calcium channel blocker, has shown potential in reducing oxidative stress and improving mitochondrial dysfunction, but its application in DU treatment remains unexplored. Methods: A dual-network QSAZ@VPH hydrogel was developed for local delivery and controlled release of verapamil. In vitro experiments evaluated its protective effects on HUVECs exposed to H2O2-induced mitochondrial dysfunction, including inflammatory marker expression, apoptosis inhibition, and angiogenesis promotion. In vivo studies used db/db mice and DU model rats to assess wound healing, granulation tissue formation, and neovascularization. Results: In vitro, QSAZ@VPH reduced mitochondrial dysfunction, lowered inflammatory markers, inhibited apoptosis, and promoted angiogenesis. In vivo, the hydrogel significantly improved wound healing in both models, reversing impaired healing and promoting granulation tissue formation and enhanced neovascularization. Conclusions: The QSAZ@VPH hydrogel presents a promising strategy for diabetic ulcer therapy by targeting mitochondrial dysfunction and promoting tissue regeneration.http://www.sciencedirect.com/science/article/pii/S0264127525006720Diabetic ulcersVerapamilHydrogel deliveryWound healingMitochondrial
spellingShingle Bin Chen
Hang Li
Yuliang Sun
Yuhua Li
Parisa Anvari
Ghazal Shokraneh
Menglin Cong
AmirMahdi Saeidi
Hecheng Ma
Tian Li
Gang Wang
Junhao Lin
Zhijian Wei
Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
Materials & Design
Diabetic ulcers
Verapamil
Hydrogel delivery
Wound healing
Mitochondrial
title Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
title_full Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
title_fullStr Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
title_full_unstemmed Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
title_short Dual-Network QSAZ@VPH hydrogel-mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
title_sort dual network qsaz vph hydrogel mediated verapamil treatment improved recovery of diabetic ulcer through inhibiting mitochondrial oxidative stress and enhancing angiogenesis
topic Diabetic ulcers
Verapamil
Hydrogel delivery
Wound healing
Mitochondrial
url http://www.sciencedirect.com/science/article/pii/S0264127525006720
work_keys_str_mv AT binchen dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT hangli dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT yuliangsun dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT yuhuali dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT parisaanvari dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT ghazalshokraneh dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT menglincong dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT amirmahdisaeidi dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT hechengma dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT tianli dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT gangwang dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT junhaolin dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis
AT zhijianwei dualnetworkqsazvphhydrogelmediatedverapamiltreatmentimprovedrecoveryofdiabeticulcerthroughinhibitingmitochondrialoxidativestressandenhancingangiogenesis